Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Alteration of UCP2 and ZO-1 Expression in Trabecular Meshwork of Neovascular Glaucoma Patients.

Yang JG, Zhou CJ, Li XY, Sun PR, Li SP, Ren BC.

J Glaucoma. 2013 Jul 3. [Epub ahead of print]

PMID:
23835672
[PubMed - as supplied by publisher]
2.

Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.

Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, Otori Y, Kamei M, Kusaka S, Tano Y.

Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28.

PMID:
18440643
[PubMed - indexed for MEDLINE]
3.

[Treatment of neovascular glaucoma by anterior retinal cryotherapy and trabeculectomy].

Ma L, Zhao B, Di Y.

Zhonghua Yan Ke Za Zhi. 1996 Mar;32(2):118-22. Chinese.

PMID:
9206228
[PubMed - indexed for MEDLINE]
4.

Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.

Sugimoto Y, Mochizuki H, Okumichi H, Takumida M, Takamatsu M, Kawamata S, Kiuchi Y.

Graefes Arch Clin Exp Ophthalmol. 2010 Nov;248(11):1601-9. doi: 10.1007/s00417-010-1406-x. Epub 2010 Jun 4.

PMID:
20524132
[PubMed - indexed for MEDLINE]
5.

Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.

Duch S, Buchacra O, Milla E, Andreu D, Tellez J.

J Glaucoma. 2009 Feb;18(2):140-3. doi: 10.1097/IJG.0b013e318170a747.

PMID:
19225351
[PubMed - indexed for MEDLINE]
6.

The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma.

Gupta V, Jha R, Rao A, Kong G, Sihota R.

Eur J Ophthalmol. 2009 May-Jun;19(3):435-41.

PMID:
19396791
[PubMed - indexed for MEDLINE]
7.

Dexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells.

Zhuo YH, He Y, Leung KW, Hou F, Li YQ, Chai F, Ge J.

Mol Vis. 2010 Jan 16;16:61-71.

PMID:
20090922
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Elevated pressure downregulates ZO-1 expression and disrupts cytoskeleton and focal adhesion in human trabecular meshwork cells.

Yang X, Liu B, Bai Y, Chen M, Li Y, Chen M, Wei Y, Ge J, Zhuo Y.

Mol Vis. 2011;17:2978-85. Epub 2011 Nov 16.

PMID:
22128243
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.

Lupinacci AP, Calzada JI, Rafieetery M, Charles S, Netland PA.

Adv Ther. 2009 Feb;26(2):208-16. doi: 10.1007/s12325-009-0001-1. Epub 2009 Feb 20.

PMID:
19234680
[PubMed - indexed for MEDLINE]
10.

Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma.

Elgin U, Berker N, Batman A, Simsek T, Cankaya B.

J Glaucoma. 2006 Oct;15(5):466-70.

PMID:
16988612
[PubMed - indexed for MEDLINE]
11.

Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.

Chen CH, Lai IC, Wu PC, Chen YJ, Chen YH, Lee JJ, Liu YC, Kuo HK.

J Ocul Pharmacol Ther. 2010 Feb;26(1):111-8. doi: 10.1089/jop.2009.0055.

PMID:
20148654
[PubMed - indexed for MEDLINE]
12.

Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.

Rönkkö S, Rekonen P, Kaarniranta K, Puustjarvi T, Teräsvirta M, Uusitalo H.

Mol Vis. 2007 Mar 26;13:408-17.

PMID:
17417602
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Visual loss after transscleral diode laser cyclophotocoagulation for primary open-angle and neovascular glaucoma.

Pokroy R, Greenwald Y, Pollack A, Bukelman A, Zalish M.

Ophthalmic Surg Lasers Imaging. 2008 Jan-Feb;39(1):22-9.

PMID:
18254347
[PubMed - indexed for MEDLINE]
14.

Histopathology of the trabecular meshwork and Schlemm's canal in primary angle-closure glaucoma.

Hamanaka T, Kasahara K, Takemura T.

Invest Ophthalmol Vis Sci. 2011 Nov 17;52(12):8849-61. doi: 10.1167/iovs.11-7591.

PMID:
21960557
[PubMed - indexed for MEDLINE]
Free Article
15.

Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.

Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H.

Am J Ophthalmol. 2009 May;147(5):912-8, 918.e1. doi: 10.1016/j.ajo.2008.11.015. Epub 2009 Feb 5.

PMID:
19195639
[PubMed - indexed for MEDLINE]
16.

Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.

Alkawas AA, Shahien EA, Hussein AM.

J Glaucoma. 2010 Dec;19(9):622-6. doi: 10.1097/IJG.0b013e3181ccb794.

PMID:
20179624
[PubMed - indexed for MEDLINE]
17.

Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens.

Yoshida N, Hisatomi T, Ikeda Y, Kohno R, Murakami Y, Imaki H, Ueno A, Fujisawa K, Ishibashi T.

Graefes Arch Clin Exp Ophthalmol. 2011 Oct;249(10):1547-52. doi: 10.1007/s00417-011-1761-2. Epub 2011 Aug 13.

PMID:
21842129
[PubMed - indexed for MEDLINE]
18.

Comparison of ultrasound biomicroscopic changes after glaucoma triple procedure and trabeculectomy in eyes with primary angle closure glaucoma.

Park SW, Heo H, Yang KJ.

J Glaucoma. 2009 Apr-May;18(4):311-5. doi: 10.1097/IJG.0b013e318184568e.

PMID:
19365197
[PubMed - indexed for MEDLINE]
19.

Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.

Yazdani S, Hendi K, Pakravan M, Mahdavi M, Yaseri M.

J Glaucoma. 2009 Oct-Nov;18(8):632-7. doi: 10.1097/IJG.0b013e3181997211.

PMID:
19826393
[PubMed - indexed for MEDLINE]
20.

Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.

Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ.

Br J Ophthalmol. 2009 May;93(5):589-93. doi: 10.1136/bjo.2008.151472. Epub 2008 Dec 15.

PMID:
19074917
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk